Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation.
Fischer
S
S
Division of Transplantation Surgery, 2nd Department of Surgery, The Cologne Merheim Hospital, University of Cologne, Cologne, Germany.
Hopkinson
D
D
Cassivi
S D
SD
Saad
S
S
Paul
A
A
D000328:Adult; D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D011239:Prednisolone / Q000627:therapeutic use*; D011446:Prospective Studies; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D011239:Prednisolone; D016559:Tacrolimus